We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRR icon
426
Red Rock Resorts
RRR
$3.61B
$248K 0.02%
7,434
+375
+5% +$15K
APH icon
427
Amphenol
APH
$209B
$247K 0.02%
+7,662
New +$266K
BAX icon
428
Baxter International
BAX
$14.4B
$247K 0.02%
+3,840
New +$279K
FLWS icon
429
1-800-Flowers.com
FLWS
$253M
$247K 0.02%
26,002
+10,561
+68% +$117K
LUMN icon
430
Lumen
LUMN
$6.82B
$247K 0.02%
+22,670
New +$254K
IBKR icon
431
Interactive Brokers
IBKR
$41B
$243K 0.02%
+17,644
New +$262K
MAC icon
432
Macerich
MAC
$6.88B
$241K 0.02%
+27,624
New +$334K
WTW icon
433
Willis Towers Watson
WTW
$32B
$240K 0.02%
+1,216
New +$261K
USFD icon
434
US Foods
USFD
$23.9B
$239K 0.02%
+7,777
New +$263K
ROP icon
435
Roper Technologies
ROP
$40.1B
$238K 0.02%
+602
New +$262K
TLYS icon
436
Tilly's
TLYS
$134M
$238K 0.02%
33,847
– –
CNA icon
437
CNA Financial
CNA
$13.9B
$236K 0.02%
5,254
-9,479
-64% -$435K
AERI
438
DELISTED
Aerie Pharmaceuticals
AERI
$236K 0.02%
+31,516
New +$222K
ESRT icon
439
Empire State Realty Trust
ESRT
$802M
$235K 0.02%
33,431
-6,319
-16% -$51.3K
PRGO icon
440
Perrigo
PRGO
$1.74B
$234K 0.02%
+5,766
New +$214K
ALDX icon
441
Aldeyra Therapeutics
ALDX
$91.7M
$231K 0.02%
+57,860
New +$199K
SEI
442
Solaris Energy Infrastructure
SEI
$3.95B
$231K 0.02%
21,255
-1,323
-6% -$15.9K
KPTI icon
443
Karyopharm Therapeutics
KPTI
$44.2M
$230K 0.02%
+3,400
New +$312K
AVB icon
444
AvalonBay Communities
AVB
$26.2B
$229K 0.02%
+1,177
New +$255K
THO icon
445
Thor Industries
THO
$4.11B
$228K 0.02%
+3,054
New +$237K
CPRT icon
446
Copart
CPRT
$27.3B
$227K 0.02%
+8,364
New +$238K
CPRX
447
DELISTED
Catalyst Pharmaceutical
CPRX
$227K 0.02%
32,338
-92,264
-74% -$677K
BBWI icon
448
Bath & Body Works
BBWI
$3.92B
$226K 0.02%
+8,402
New +$365K
BZUN
449
Baozun
BZUN
$171M
$225K 0.02%
+20,579
New +$181K
MKSI icon
450
MKS Inc
MKSI
$20B
$225K 0.02%
+2,189
New +$255K
16 17
18
19 20

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.